DaVita Inc. (DVA)
undefined
undefined%
At close: undefined
152.73
-0.05%
After-hours Dec 13, 2024, 07:00 PM EST

Company Description

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure.

The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers.

It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services.

As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients.

Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States.

The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016.

DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

DaVita Inc.
DaVita Inc. logo
Country United States
IPO Date Oct 31, 1995
Industry Medical - Care Facilities
Sector Healthcare
Employees 70,000
CEO Javier J. Rodriguez

Contact Details

Address:
2000 16th Street
Denver, Colorado
United States
Website https://www.davita.com

Stock Details

Ticker Symbol DVA
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000927066
CUSIP Number 23918K108
ISIN Number US23918K1088
Employer ID 51-0354549
SIC Code 8090

Key Executives

Name Position
Javier J. Rodriguez Chief Executive Officer & Executive Director
David Maughan Chief Operating Officer
Jessica Hergenreter Chief People Officer
Joel Ackerman Chief Financial Officer & Treasurer
Madhu Narasimhan Chief Information Officer
Christopher Michael Berry CPA Group Vice President & Chief Accounting Officer
James O. Hearty Chief Compliance Officer
Kathleen Alyce Waters Chief Legal & Public Affairs Officer
Misha Palecek Chief Transformation Officer of U.S. Kidney Care Business
Nic Eliason Group Vice President of Investor Relations

Latest SEC Filings

Date Type Title
Dec 05, 2024 4 Filing
Nov 27, 2024 4 Filing
Nov 19, 2024 4 Filing
Nov 19, 2024 4 Filing
Nov 19, 2024 4 Filing
Nov 19, 2024 4 Filing
Nov 19, 2024 4 Filing
Nov 19, 2024 4 Filing
Nov 19, 2024 4 Filing
Nov 19, 2024 4 Filing